Zhang, L., Zhao, X., Tao, G
Animal studies further support its therapeutic potential
Orforglipron Phase 3 data showed gallbladder-related events at rates modestly above placebo, consistent with the class effect
In response to this crisis, glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as a groundbreaking class of medications for weight management
Compounding pharmacies have stepped in to fill the gap and help relieve the shortage, using permissions granted in guidance from the FDA
Here, we investigate a descending circuit formed by GLP-1 receptor (GLP-1R) neurons in the paraventricular hypothalamic nucleus (PVN GLP-1R ) projecting to the dorsal vagal complex (DVC) of the brain stem in mice